Hadassah Medical Organization

Hadassah Medical Organization is a major non-profit academic medical center in Jerusalem, Israel, home to the Hadassah BrainLabs Center for Psychedelic Research, which develops novel psychedelic-based treatments for psychiatric disorders. The organization runs MDMA-assisted psychotherapy trials for PTSD (NCT06954025) and ketamine trials for depression (NCT05026203), and serves as the Phase 1 clinical pharmacology site for Ketamir-2, a novel oral ketamine analog.